Medifocus, Inc.
1ME
| 12/31/2019 | 09/30/2019 | ||||
|---|---|---|---|---|---|
| Revenue | 0.13% | -5.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.13% | -5.80% | |||
| Cost of Revenue | 2.75% | -7.05% | |||
| Gross Profit | -5.49% | -2.98% | |||
| SG&A Expenses | -19.18% | 20.76% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -8.32% | 4.90% | |||
| Operating Income | 26.19% | -38.02% | |||
| Income Before Tax | 11.14% | -13.04% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 11.14% | -13.04% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 11.14% | -13.04% | |||
| EBIT | 26.19% | -38.02% | |||
| EBITDA | 27.68% | -66.98% | |||
| EPS Basic | 11.11% | -12.50% | |||
| Normalized Basic EPS | 11.76% | -13.33% | |||
| EPS Diluted | 11.11% | -12.50% | |||
| Normalized Diluted EPS | 11.76% | -13.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||